These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37330370)

  • 1. Preclinical evaluation of performance, safety and usability of VAX-ID®, a novel intradermal injection device.
    Beyers KCL; Rbeihat MNM; S Vasconcelos D; Pasmans D; Verwulgen S; Vankerckhoven VVJ
    Vaccine; 2023 Jul; 41(31):4609-4615. PubMed ID: 37330370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and safety of intradermal delivery of hepatitis B booster vaccine using the novel drug delivery device VAX-ID™.
    Van Mulder TJS; Withanage K; Beyers KCL; Vankerckhoven VVJ; Theeten H; Van Damme P
    Vaccine; 2019 Jan; 37(4):581-586. PubMed ID: 30587432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of acceptability and usability of new delivery prototype device for intradermal vaccination in healthy subjects.
    Van Mulder TJ; Verwulgen S; Beyers KC; Scheelen L; Elseviers MM; Van Damme P; Vankerckhoven V
    Hum Vaccin Immunother; 2014; 10(12):3746-53. PubMed ID: 25531808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance and usability evaluation of novel intradermal injection device Immucise™ and reanalysis of intradermal administration trials of influenza vaccine for the elderly.
    Shimizu S; Tanaka R; Itoh E; Maekawa-Matsuura M; Iwase Y
    Vaccine; 2022 Feb; 40(6):873-879. PubMed ID: 35031147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usability evaluation of intradermal adapters (IDA).
    Tsals I
    Vaccine; 2017 Mar; 35(14):1797-1801. PubMed ID: 27496277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
    Van Damme P; Oosterhuis-Kafeja F; Van der Wielen M; Almagor Y; Sharon O; Levin Y
    Vaccine; 2009 Jan; 27(3):454-9. PubMed ID: 19022318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin thickness measurements for optimal intradermal injections in children.
    Van Mulder TJS; Van Nuffel D; Demolder M; De Meyer G; Moens S; Beyers KCL; Vankerckhoven VVJ; Van Damme P; Theeten H
    Vaccine; 2020 Jan; 38(4):763-768. PubMed ID: 31767463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intradermal delivery for vaccine dose sparing: overview of current issues.
    Zehrung D; Jarrahian C; Wales A
    Vaccine; 2013 Jul; 31(34):3392-5. PubMed ID: 23176978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High frequency ultrasound to assess skin thickness in healthy adults.
    Van Mulder TJ; de Koeijer M; Theeten H; Willems D; Van Damme P; Demolder M; De Meyer G; Beyers KC; Vankerckhoven V
    Vaccine; 2017 Mar; 35(14):1810-1815. PubMed ID: 27496276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical development of an automated injection device for intradermal delivery of a cell-based therapy.
    Leoni G; Lyness A; Ginty P; Schutte R; Pillai G; Sharma G; Kemp P; Mount N; Sharpe M
    Drug Deliv Transl Res; 2017 Oct; 7(5):695-708. PubMed ID: 28812281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery systems for intradermal vaccination.
    Kim YC; Jarrahian C; Zehrung D; Mitragotri S; Prausnitz MR
    Curr Top Microbiol Immunol; 2012; 351():77-112. PubMed ID: 21472533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of a novel microneedle device for intradermal delivery of an influenza vaccine: are all delivery methods the same?
    Levin Y; Kochba E; Kenney R
    Vaccine; 2014 Jul; 32(34):4249-52. PubMed ID: 24930715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intradermal vaccination with un-adjuvanted sub-unit vaccines triggers skin innate immunity and confers protective respiratory immunity in domestic swine.
    Le Luduec JB; Debeer S; Piras F; Andréoni C; Boudet F; Laurent P; Kaiserlian D; Dubois B
    Vaccine; 2016 Feb; 34(7):914-22. PubMed ID: 26768129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intradermal vaccination for infants and children.
    Saitoh A; Aizawa Y
    Hum Vaccin Immunother; 2016 Sep; 12(9):2447-55. PubMed ID: 27135736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability of intramuscular and intradermal delivery by CELLECTRA(®) adaptive constant current electroporation device in healthy volunteers.
    Diehl MC; Lee JC; Daniels SE; Tebas P; Khan AS; Giffear M; Sardesai NY; Bagarazzi ML
    Hum Vaccin Immunother; 2013 Oct; 9(10):2246-52. PubMed ID: 24051434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of PRRSV-2 MLV vaccines administrated via the intramuscular or intradermal route and evaluation of PRRSV transmission upon needle-free and needle delivery.
    Madapong A; Saeng-Chuto K; Tantituvanont A; Nilubol D
    Sci Rep; 2021 Nov; 11(1):23107. PubMed ID: 34845289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical performance and safety of adapters for intradermal delivery with conventional and autodisable syringes.
    Tsals I; Jarrahian C; Snyder FE; Saganic L; Saxon E; Zehrung D; Zimmerman G; Papania M; Klaff L
    Vaccine; 2015 Sep; 33(37):4705-11. PubMed ID: 25964169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing immunogenicity of antigens through sustained intradermal delivery using chitosan microneedles with a patch-dissolvable design.
    Chen MC; Lai KY; Ling MH; Lin CW
    Acta Biomater; 2018 Jan; 65():66-75. PubMed ID: 29109028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Devices for intradermal vaccination.
    Kis EE; Winter G; Myschik J
    Vaccine; 2012 Jan; 30(3):523-38. PubMed ID: 22100637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunological effects of intradermal particle-based vaccine delivery using a novel microinjection needle studied in a human skin explant model.
    Beaujean M; Uijen RF; Langereis JD; Boccara D; Dam D; Soria A; Veldhuis G; Adam L; Bonduelle O; van der Wel NN; Luirink J; Pedruzzi E; Wissink J; de Jonge MI; Combadière B
    Vaccine; 2023 Mar; 41(13):2270-2279. PubMed ID: 36870875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.